Meihua International Medical Technologies Co Ltd's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Meihua International Medical Technologies Co Ltd in the fourth quarter 2025?
Meihua International Medical Technologies Co Ltd achieved a return on average equity (ROE) of 3.71 % in its fourth quarter 2025, which is below Meihua International Medical Technologies Co Ltd's average return on equity, which stands at 5.35%.

ROE fell compared to the third quarter 2025, despite the net income growth of % from the third quarter 2025.

Within the Medical Equipment & Supplies industry 61 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the third quarter 2025 from to 2296.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Dec 31 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2023) IV. Quarter
Y / Y Equity Change	18.84 %	26.31 %	12.33 %	28.67 %	-
Y / Y Net Income Change	-41.49 %	-	-	-	87.63 %
Net Income (TTM) in Millions	7	12	12	12	12
Return On Equity (TTM)	3.71 %	6.61 %	7 %	7.2 %	7.7 %
MHUA's Total Ranking	# 2296	#	#	#	#
Equity (TTM) in Millions	189	189	165	189	159
Seq. Equity Change	0 %	14.54 %	-12.7 %	18.84 %	6.29 %
Seq. Net Income Change	-	-	-	-	-

Back to MHUA Management Effectiveness >> MHUA's 5 Years Annual ROE >> Compare MHUA ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 62
Sector	# 199
Overall	# 2296

Return On Equity Statistics
High	Average	Low
7.89 %	5.35 %	3.71 %
(Dec 31 2023)		(Dec 31 2025)

MHUA Annual Return On Equity	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Equity in Millions	189	159	147	139	108
Y / Y Equity Change	18.84 %	8.27 %	5.88 %	28.68 %	-
Net Income in Millions	7	11	12	6	21
Y / Y Net Income Change	-37.42 %	-6.5 %	87.63 %	-70.51 %	-
Return On Equity	3.59 %	6.82 %	7.89 %	4.45 %	19.44 %

Back to MHUA Management Effectiveness >> MHUA's 5 Years Annual ROE >> Compare MHUA ROE to its Competitors

Annual Roe Comment

In 2025 ROE decreased compared to the previous year to 3.59 %, due to deterioration of net income.

More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
MHUA's' Return on Equity at Yahoo Finance
MHUA's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for MHUA's Competitors
Subscribers only: Roe for Meihua International Medical Technologies Co Ltd's Suppliers
Subscribers only: Return On Equity for MHUA's Customers

Companies with similar Return On Equity at Dec 31 2025, within Healthcare Sector	ROE
Profound Medical Corp	10.12 %
Galapagos Nv	9.92 %
The Pennant Group Inc	9.83 %
Organogenesis Holdings Inc	9.63 %
Emergent Biosolutions Inc	9.59 %
Utah Medical Products Inc	9.56 %
Medtronic Plc	9.54 %
Stevanato Group S p a	9.41 %
Tactile Systems Technology Inc	9.26 %
Addus Homecare Corp	9.24 %
Pfizer Inc	8.69 %
Merit Medical Systems Inc	8.52 %
Fresenius Medical Care Ag	8.34 %
Apellis Pharmaceuticals Inc	8.20 %
Koninklijke Philips Nv	8.16 %
Galmed Pharmaceuticals Ltd	7.75 %
Gyre Therapeutics Inc	7.70 %
Beone Medicines Ltd	7.28 %
Biogen Inc	7.28 %
Becton Dickinson And Company	6.93 %
Talkspace Inc	6.89 %
Grifols Sa	6.58 %
Integer Holdings Corporation	6.05 %
Soleno Therapeutics Inc	5.90 %
Biomarin Pharmaceutical Inc	5.82 %
Fonar Corporation	5.75 %
Vaso Corporation	5.66 %
Zimmer Biomet Holdings Inc	5.60 %
Veracyte Inc	5.33 %
Vericel Corporation	5.17 %

Date modified: 2026-07-07T11:58:39+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.